M-HA30 Architect Device

· Laboratoires FILLMED

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M-HA30 Architect Device, covering 2025-06-05 to 2025-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study [NA]

See pricing